Glaxo Wellcome GmbH, Germany
| Държава: | Германия |
| Кратка информация: | Strong values are central to business success. We place great importance not just on what we achieve but on how we achieve it. Being a responsible business means connecting our business decisions to society’s healthcare needs and operating in a way that reflects our values: Commit to transparency Show respect for people Always demonstrate the highest integrity in our conduct Be patient focused Our values underpin our Principles which outline the standards which GSK is committed. Our Corporate Responsibility Committee of Non-Executive Directors provides high-level guidance on our approach to CR. Accountability for the responsible management of GSK sits with the CEO and members of the Corporate Executive Team. We know that the research and development, manufacture and sale of our products can raise ethical issues, and we aim to be open about how we tackle them. We understand it is important to communicate with our stakeholders, seeking to understand their views, being transparent about any setbacks we have experienced as well as the progress we have made. Read more about our approach in CR at GSK and in the sections below. Access to medicines Providing access to healthcare is one of society’s most pressing social challenges. We want to increase access to our medicines and vaccines to all patients, irrespective of where they live and their ability to pay. We believe it is the right thing to do and know that it will contribute to our business success. By striving to meet society’s healthcare needs we build trust in our business, which helps to safeguard our licence to operate in the long term. Our access strategy focuses on areas where we can make the most difference through our core business activities, skills and resources. In particular this means initiatives to improve affordability and to conduct and encourage more investment in R&D for the developing world. To achieve this we are: Pursuing flexible pricing strategies Refocusing our R&D activities to reflect the needs of developing countries Seeking innovative partnerships to try to reach people who would otherwise not have access to our medicines and vaccines. Read more in Access to medicines. Research practices Investment in R&D into new medicines and vaccines is at the core of our business. We focus our R&D efforts on areas where there is greatest patient need and where advances in science offer the best opportunities to discover new medicines and generate commercial returns. Our aim is for new treatments to provide value over currently available treatments to both patients and to payers. Patient safety is always our priority and we evaluate the benefits and risks of our medicines at all stages of research and after a new product is approved for sale. We are committed to transparency and to disclosing the results of our clinical research. It is essential that we meet consistently high quality and ethical standards in all our R&D, in all parts of our business, and in all the markets where we operate. This enables us to protect the safety of clinical trial participants and the patients who use our medicines, to obtain regulatory approval for new medicines and vaccines, and to maintain the trust of patients and healthcare professionals. We recognise that biomedical research can raise ethical concerns, including those related to animal research, the use of emerging technologies such as stem cell research and clinical trial standards. We aim to address these by being open about our approach and regularly engage with stakeholders on these issues. Read more in Research practices . Ethical conduct We are building a strong ethical culture at GSK. We do this by developing robust policies, recruiting the right people and equipping them with the information they need to make ethical decisions. Putting patients first is the core principle of being an ethical healthcare company. All employees must understand what we stand for as well as the policies and procedures that underpin our approach. They must comply with our Code of Conduct which sets out our fundamental standards, and follow our Employee Guide to Business Conduct which helps employees make ethical decisions and emphasises our company values. Our internal compliance systems are designed to support ethical behaviour and decision making by employees, and to identify and address breaches of our codes. Read more in Ethical conduct. Supply chain Patients depend on an uninterrupted supply of medicines, manufactured to the highest quality standards. An effective and responsibly managed supply and distribution system is essential for us to get high quality products to the right place at the right time. To meet patients’ needs we must protect our complex supply and distribution chain from disruption. We must also ensure that products are stored correctly and handled carefully throughout distribution and at their destination. We aim to source from companies that maintain high standards for quality, labour and the environment, and protect their employees’ human rights. Our standards are explained in our Third Party Code of Conduct, and the EHS and human rights clauses in supplier contracts. Our approach also includes regular supplier performance reviews, audits and training. We put measures in place to detect and prevent counterfeiting of our products, which can endanger patient health and lead to loss of revenue. Read more in Supply chain. Environmental sustainability We are integrating environmental sustainability into our business. We have a responsibility to contribute to meeting environmental challenges, but we also see this as an opportunity. Our focus is on carbon dioxide and other emissions that contribute to climate change, water use, and environmental stewardship which covers the use of materials and generation of waste. We conduct life cycle assessments of key products to identify and reduce their full environmental footprint. We have set ambitious environmental sustainability goals to reduce the impact of our own operations and our value chain, from raw materials to product disposal. Our long-term goal is for our value chain to be carbon neutral by 2050. In the shorter term we have set demanding targets for reducing our carbon footprint by 25% and water use by 20% by 2020. Read more in Environmental sustainability. Our people We employ over 90,000 people in 114 countries worldwide. We want GSK to be known as a great place to work and an employer of choice for talented people from all backgrounds. Our employment practices help us create the right workplace culture in which all GSK employees feel valued, respected, empowered and inspired. Important elements of our approach include our commitment to inclusion and diversity and support for flexible working practices; regular two-way communication with employees; and respectful and fair treatment of employees during changes to the company. Our leaders set the tone from the top, and all employees have a role to play in maintaining this culture. We ask them to adopt our company values and behaviours in all their work, and in return we aim to provide a great employee experience for everyone at GSK which includes high-quality training and development opportunities and competitive reward packages. Keeping employees and contractors healthy and safe is a priority. Our rigorous management system reduces the risk of harm to people working at GSK and helps them remain healthy, productive and energised. Read more in Our people. Human rights We work hard to protect human rights within our sphere of influence, which includes employees, suppliers, local communities and society more broadly. We have most direct control over human rights in our own operations. We are committed to upholding the UN Universal Declaration of Human Rights, the OECD Guidelines for Multi-National Enterprises and the core labour standards set out by the International Labour Organization. We are a signatory to the UN Global Compact, a voluntary global standard on human rights, labour, the environment and anti-corruption. Maintaining high standards of human rights benefits our business by helping us get the best from our employees, supporting our relationships with communities near our sites, ensuring supplier contracts run smoothly and provide a reliable supply of high-quality products, and by protecting our reputation. Read more in Human rights. Public policy and patient advocacy Through our public policy activity we work towards legislation and policy that encourage scientific innovation and balance the interests of business with those of other stakeholders. We also work with patient groups and professional groups to help give their members a voice in the healthcare debate. We believe that we conduct our advocacy work responsibly and make a valuable contribution to the debate on issues that impact our business, particularly those relating to research and development, the use of pharmaceuticals and healthcare. We aim to increase stakeholder trust in GSK and, by being transparent about our lobbying and public policy work, to address concerns from some stakeholders that the pharmaceutical industry exercises inappropriate influence over governments. We publish key elements of our annual public policy activity on this website and report on our trade association memberships and US Federal and EU institution lobbying expenditures. We also publish information on our work with patient groups, including details of the funding we provide. GSK does not make political contributions. Read more in Public policy and patient advocacy. Our work with communities We invest in community partnership programmes that seek to improve access to medicines and healthcare around the world, and create opportunities in education and economic development. We aim to make a real difference to communities by working with our partners to find innovative solutions to healthcare challenges. Our programmes include global initiatives designed to tackle diseases of the developing world across multiple countries. We also support local programmes that are tailored to the specific needs and challenges of our many different markets. Our support includes donations of time, money, expertise and medicines. We encourage employees to get involved through our volunteering programmes because this benefits the organisations and charities we support and contributes to employees’ personal development. Read more in Our work with communities. |
| Сайт: | http://www.gsk.com |
Търсене в сайта
Лекарствен справочник
http://sommons.co/out?zoneId=2647810-2647961 Банер II
